Ley Sander

Q: What Schools Are Affiliated With Ley Sander

Ley Sander is affiliated with the following schools: University College London, Federal University of Paraná, Sichuan University

Ley Sander's AcademicInfluence.com Rankings

Ley Sander

Medical

#187

World Rank

#281

Historical Rank

Neurology

#15

World Rank

#38

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Ley Sander Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Josemir W. Sander, also known as Ley Sander, is the ES Professor of Neurology and Clinical Epilepsy at the Department of Clinical and Experimental Epilepsy, Institute of Neurology of University College London. He is Honorary Consultant Neurologist and Clinical Lead for Epilepsy at the National Hospital for Neurology and Neurosurgery, Queen Square, London and at the Epilepsy Society's Sir William Gowers Assessment Centre in Buckinghamshire. Sander is Head of the World Health Organization Collaborating Centre for Research and Training in Neurosciences, London and Medical Director of the Epilepsy Society, based at the Chalfont Centre for Epilepsy. Sander is also the Director for Scientific Research at SEIN – in Heemstede.

(See a Problem?)

Ley Sander's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estimation of the burden of active and life-time epilepsy: A meta-analytic approach (2010) (1130)
Standards for epidemiologic studies and surveillance of epilepsy (2011) (850)
The epidemiology of epilepsy revisited (2003) (845)
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. (2000) (807)
The global burden and stigma of epilepsy (2008) (734)
The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study (2011) (675)
Recommendation for a definition of acute symptomatic seizure (2010) (611)
Adult epilepsy (2006) (551)
The Epidemiology of the Comorbidity of Epilepsy in the General Population (2004) (540)
Epidemiology of the epilepsies. (1996) (471)
Some Aspects of Prognosis in the Epilepsies: A Review (1993) (410)
Epilepsy in adults (2019) (408)
Combined analysis of risk factors for SUDEP (2011) (407)
Case-control study of SUDEP (2005) (400)
Comorbidities of epilepsy: current concepts and future perspectives (2016) (391)
Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms (2009) (388)
The natural history of epilepsy: an epidemiological view (2004) (359)
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. (2005) (355)
Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. (1996) (352)
The psychiatric comorbidity of epilepsy (2004) (352)
The treatment of epilepsy in developing countries: where do we go from here? (2001) (333)
Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations (2011) (332)
Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long‐term, prospective, population‐based cohort (2001) (321)
Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. (2006) (314)
Prognosis of Epilepsy: A Review and Further Analysis of the First Nine Years of the British National General Practice Study of Epilepsy, a Prospective Population‐Based Study (1997) (307)
Infections, inflammation and epilepsy (2016) (301)
Sudden Unexpected Death in Epilepsy: A Review of Incidence and Risk Factors (2005) (301)
Sudden Death in Epilepsy: A Study of Incidence in a Young Cohort with Epilepsy and Learning Difficulty (1995) (299)
Sudden unexpected death in epilepsy: a series of witnessed deaths (2000) (289)
Predictors of health‐related quality of life and costs in adults with epilepsy: A systematic review (2011) (280)
Incidence and prevalence studies in epilepsy and their methodological problems: a review. (1987) (276)
Incidence of epilepsy (2011) (275)
Sudden unexpected death in epilepsy: People with nocturnal seizures may be at highest risk (2012) (269)
Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. (1995) (268)
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors (2017) (267)
New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study (2020) (264)
Psychiatric adverse events during levetiracetam therapy (2003) (258)
Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies (2013) (251)
Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2017) (250)
Mortality of Epilepsy in Developed Countries: A Review (2005) (247)
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. (2010) (240)
Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy (2007) (237)
Do antiepileptic drugs or generalized tonic–clonic seizure frequency increase SUDEP risk? A combined analysis (2012) (237)
Effects of topiramate on cognitive function (2000) (233)
The long-term risk of premature mortality in people with epilepsy. (2011) (233)
Cardiac arrhythmias during or after epileptic seizures (2015) (221)
Factors predicting prognosis of epilepsy after presentation with seizures (2000) (221)
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies (2018) (213)
Topiramate and Psychiatric Adverse Events in Patients with Epilepsy (2003) (212)
The burden of premature mortality of epilepsy in high‐income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy (2016) (206)
Assessing the psychosocial consequences of epilepsy: a community-based study. (1999) (204)
Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. (1992) (197)
The cost of epilepsy in the United Kingdom: An estimation based on the results of two population-based studies (1994) (197)
Minimally Invasive Craniopuncture Therapy vs. Conservative Treatment for Spontaneous Intracerebral Hemorrhage: Results from a Randomized Clinical Trial in China (2009) (194)
The excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy (1993) (193)
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study (2007) (189)
The National Hospital Seizure Severity Scale: A Further Development of the Chalfont Seizure Severity Scale (1996) (189)
Mortality in patients with epilepsy: a study of patients in long term residential care. (1993) (184)
Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England (2002) (183)
The Epidemiology of the Epilepsies: Future Directions (1997) (178)
The Use of Antiepileptic Drugs—Principles and Practice (2004) (175)
CPD — Education and self-assessment The epidemiology of epilepsy: the size of the problem (2001) (169)
Progressive neocortical damage in epilepsy (2003) (166)
Postictal generalized electroencephalographic suppression is associated with generalized seizures (2011) (164)
The somatic comorbidity of epilepsy: A weighty but often unrecognized burden (2012) (161)
Circumstances of death in sudden death in epilepsy: interviews of bereaved relatives (1998) (159)
Omega-3 fatty acid supplementation in patients with chronic epilepsy: A randomized trial (2005) (157)
Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. (1995) (154)
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study (2010) (152)
Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. (1992) (151)
The prevalence and treatment gap in epilepsy in China (2003) (150)
Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. (2005) (149)
An unknown quantity—The worldwide prevalence of epilepsy (2014) (142)
Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy (2004) (141)
The Chalfont Seizure Severity Scale. (1991) (139)
A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy (1990) (137)
Suicide in people with epilepsy: How great is the risk? (2009) (135)
The epidemiology of epilepsy: the size of the problem. (2001) (134)
A meta‐analysis of white matter changes in temporal lobe epilepsy as studied with diffusion tensor imaging (2012) (131)
Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case–control study (2010) (128)
The natural history and prognosis of epilepsy. (2015) (127)
Disease modification in partial epilepsy. (2002) (126)
Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death (2010) (126)
Mortality in Dravet syndrome: A review (2016) (123)
Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. (2012) (123)
The characteristics of epilepsy in a largely untreated population in rural Ecuador. (1994) (122)
Factors Influencing the Incidence of Lamotrigine-Related Skin Rash (1999) (121)
Cause‐Specific Mortality in Epilepsy (2005) (121)
Cerebral Damage in Epilepsy: A Population‐based Longitudinal Quantitative MRI Study (2005) (119)
Long-term continuation of levetiracetam in patients with refractory epilepsy (2001) (119)
Prognostic Factors Affecting Long‐Term Retention of Topiramate in Patients with Chronic Epilepsy (2000) (118)
Keeping people with epilepsy safe during the COVID-19 pandemic (2020) (117)
Life expectancy in people with newly diagnosed epilepsy. (2004) (117)
Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study (2018) (117)
Premature mortality in people with epilepsy in rural China: a prospective study (2006) (116)
Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study (2005) (115)
The ketogenic and related diets in adolescents and adults—A review (2011) (112)
Surgical treatment for epilepsy: the potential gap between evidence and practice (2016) (110)
Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy (2016) (106)
Prevalence and Pattern of Epilepsy Treatment in Different Socioeconomic Classes in Brazil (2007) (106)
PRRT2 gene mutations (2012) (106)
Long‐Term Retention Rates of Lamotrigine, Gabapentin, and Topiramate in Chronic Epilepsy (2000) (103)
Forced normalization at the interface between epilepsy and psychiatry (2002) (102)
Cancer risk in people with epilepsy: the role of antiepileptic drugs. (2004) (101)
New onset neurologic events in people with COVID-19 in 3 regions in China (2020) (100)
Complex partial status epilepticus: a recurrent problem. (1994) (98)
From seizures to epilepsy and its substrates: Neurocysticercosis (2013) (97)
Topiramate and word-finding difficulties in patients with epilepsy (2003) (96)
Are Psychiatric Adverse Events of Antiepileptic Drugs a Unique Entity? A Study on Topiramate and Levetiracetam (2007) (96)
Structural imaging biomarkers of sudden unexpected death in epilepsy (2015) (94)
Incidence of photosensitive epilepsy: a prospective national study. (1995) (92)
The Limbic System Conception and Its Historical Evolution (2011) (91)
A crossover, add-on trial of talampanel in patients with refractory partial seizures (2002) (90)
Patients’ perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy (2000) (90)
Premature mortality risk in people with convulsive epilepsy: Long follow‐up of a cohort in rural China (2013) (88)
Epilepsy is a neurological and a systemic disorder (2018) (87)
The Long-Term Safety of Antiepileptic Drugs (2013) (87)
First seizures associated with playing electronic screen games: A community‐based study in Great Britain (1995) (87)
Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment (1993) (86)
The mortality of epilepsy revisited. (2004) (86)
New diagnostic criteria for neurocysticercosis: Reliability and validity (2016) (85)
Pregabalin: A new antiepileptic drug for refractory epilepsy (2006) (84)
Seizure Aggravation in Idiopathic Generalized Epilepsies (2005) (83)
Suicidality in People Taking Antiepileptic Drugs (2009) (82)
Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam (2004) (82)
The heart of epilepsy: Current views and future concepts (2017) (81)
Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment (2006) (81)
A Prospective Study of the Requirement for and the Provision of Epilepsy Surgery in the United Kingdom (2003) (81)
The structural consequences of newly diagnosed seizures (2002) (80)
Postictal generalized EEG suppression (2013) (80)
Global campaign against epilepsy: assessment of a demonstration project in rural China. (2008) (80)
Neurocysticercosis and epilepsy in developing countries (2000) (77)
The subjective handicap of epilepsy. A new approach to measuring treatment outcome. (1998) (76)
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy (2003) (75)
Screening for depression in people with epilepsy: Comparative study among Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Hospital Anxiety and Depression Scale Depression Subscale (HADS-D), and Beck Depression Inventory (BDI) (2014) (75)
Temporal trends in the mortality of people with epilepsy: A review (2010) (75)
Epilepsy in older people (2020) (74)
Postictal generalized EEG suppression is not associated with periictal cardiac autonomic instability in people with convulsive seizures (2013) (74)
Epilepsy Is a Risk Factor for Sudden Cardiac Arrest in the General Population (2012) (73)
Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2 (2019) (73)
Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy (2015) (72)
Prrt2 gene mutations: From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine (2012) (72)
Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: A pharmacodynamic interaction? (2011) (72)
Do alterations in inter-ictal heart rate variability predict sudden unexpected death in epilepsy? (2009) (71)
Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non–protein‐bound concentrations (2017) (71)
Measuring outcomes of treatment with antiepileptic drugs in clinical trials (2010) (70)
National Sentinel clinical audit of epilepsy-related death: report 2002. Epilepsy - death in the shadows (2002) (69)
Antiepileptic drugs: generic versus branded treatments (2007) (69)
Talampanel, a New Antiepileptic Drug: Single‐ and Multiple‐dose Pharmacokinetics and Initial 1‐Week Experience in Patients with Chronic Intractable Epilepsy (2003) (69)
Neurocysticercosis: A natural human model of epileptogenesis (2015) (68)
Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa (2013) (68)
Stigma Scale of Epilepsy: validation process. (2007) (66)
The Long‐Term Use of Gabapentin, Lamotrigine, and Vigabatrin in Patients with Chronic Epilepsy (1999) (65)
Neuropsychological effects of tiagabine, a potential new antiepileptic drug (1994) (65)
Surgical treatment of patients with single and dual pathology (1997) (65)
The potential neurological effect of the COVID‐19 vaccines: A review (2021) (65)
The lifelong course of chronic epilepsy: the Chalfont experience. (2013) (65)
Suicide and epilepsy (2009) (63)
How refractory is refractory epilepsy? Patterns of relapse and remission in people with refractory epilepsy (2011) (62)
Newer Antiepileptic Drugs (1994) (61)
The Role of Hippocampal Sclerosis in Topiramate‐related Depression and Cognitive Deficits in People with Epilepsy (2003) (60)
Psychosocial aspects of epilepsy: a wider approach (2016) (60)
The Mortality Associated with Epilepsy, with Particular Reference to Sudden Unexpected Death: A Review (1997) (60)
Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study (2018) (60)
An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy (1992) (59)
Increased prevalence of ECG markers for sudden cardiac arrest in refractory epilepsy (2014) (59)
The incidence and prevalence of epilepsy (2001) (58)
Premature mortality in refractory partial epilepsy: does surgical treatment make a difference? (2010) (58)
Dynamics of convulsive seizure termination and postictal generalized EEG suppression (2017) (57)
Neuropsychological outcomes in epilepsy surgery patients with unilateral hippocampal sclerosis and good preoperative memory function (2013) (57)
Causes of death among people with convulsive epilepsy in rural West China (2011) (57)
Premature mortality in active convulsive epilepsy in rural Kenya (2014) (57)
Drug therapy for solitary cysticercus granuloma (2013) (56)
Prejudice towards chronic diseases: Comparison among epilepsy, AIDS and diabetes (2007) (56)
The role of titration schedule of topiramate for the development of depression in patients with epilepsy (2009) (56)
Sudden unexpected death in epilepsy (1999) (55)
A large-scale study of epilepsy in Ecuador: methodological aspects. (1992) (55)
Reducing mortality: an important aim of epilepsy management (2004) (54)
Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. (1990) (54)
Outcome of seizures in the general population after 25 years: a prospective follow-up, observational cohort study (2016) (54)
Suicidal ideation in epilepsy and levetiracetam therapy (2007) (54)
Association of Piriform Cortex Resection With Surgical Outcomes in Patients With Temporal Lobe Epilepsy. (2019) (54)
Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk. (1996) (53)
Cause of death and predictors of mortality in a community-based cohort of people with epilepsy (2016) (53)
The global burden of epilepsy report: Implications for low- and middle-income countries (2020) (52)
Saliva and serum lacosamide concentrations in patients with epilepsy (2010) (52)
Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data (2018) (52)
Cortical excitability as a potential Clinical Marker of epilepsy: a Review of the Clinical Application of Transcranial magnetic Stimulation (2014) (51)
Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy (2014) (51)
Febrile Convulsions in 220 Children – Neurological Sequelae at 12 Years Follow-Up (1999) (50)
Sudden unexpected death in epilepsy. (2012) (50)
The long term retention of levetiracetam in a large cohort of patients with epilepsy (2005) (50)
Epilepsy stigma perception in an urban area of a limited-resource country (2007) (49)
Vigabatrin and behaviour disturbances (1990) (49)
Carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy (2017) (49)
Development and Validation of a Prognostic Model of Swallowing Recovery and Enteral Tube Feeding After Ischemic Stroke (2019) (49)
Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation (2013) (48)
Ultimate success in epilepsy – the patient's perspective (2005) (48)
Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction (2002) (48)
Nocturnal supervision and SUDEP risk at different epilepsy care settings (2018) (48)
Retinal nerve fiber layer thickness in Vigabatrin‐exposed patients (2011) (47)
Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis (2004) (47)
Microdysgenesis with abnormal cortical myelinated fibres in temporal lobe epilepsy: a histopathological study with calbindin D‐28‐K immunohistochemistry (2000) (47)
[National demonstration project on epilepsy in Brazil]. (2003) (46)
Audit of practice in sudden unexpected death in epilepsy (SUDEP) post mortems and neuropathological findings (2015) (46)
Cortisol fluctuations relate to interictal epileptiform discharges in stress sensitive epilepsy. (2016) (46)
Serum brain‐derived neurotrophic factor levels in epilepsy (2014) (46)
National General Practice Study of Epilepsy and Epileptic Seizures: objectives and study methodology of the largest reported prospective cohort study of epilepsy. National General Practice Study of Epilepsy and Epileptic Seizures (NGPSE). (1989) (46)
A High-Performance Liquid Chromatography Assay to Monitor the New Antiepileptic Drug Lacosamide in Patients With Epilepsy (2010) (46)
Refractory juvenile myoclonic epilepsy: a meta‐analysis of prevalence and risk factors (2018) (45)
In Situ Metabolism of Levetiracetam in Blood of Patients with Epilepsy (2006) (45)
Certification of deaths attributable to epilepsy (2002) (45)
Association between epilepsy and cysticercosis and toxocariasis: A population‐based case–control study in a slum in India (2012) (45)
Perampanel Serum Concentrations in Adults With Epilepsy: Effect of Dose, Age, Sex, and Concomitant Anti-Epileptic Drugs (2016) (44)
Caffeine and seizures: A systematic review and quantitative analysis (2018) (44)
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11–14 years (2001) (44)
Teachers perception about epilepsy. (2007) (44)
Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy (2010) (44)
Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China (2006) (43)
Information recalled by women taking anti-epileptic drugs for epilepsy: a questionnaire study (2002) (43)
Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management (2003) (43)
Mortality and morbidity rates are increased in people with epilepsy: Is stress part of the equation? (2007) (42)
Factors affecting seizure outcome after epilepsy surgery: an observational series (2017) (42)
Managing anti‐epileptic drug treatment in adult patients with intellectual disability: a serious conundrum (2016) (42)
Stigma and epilepsy: The Chinese perspective (2010) (42)
Long-term risk of developing epilepsy after febrile seizures (2012) (41)
Sudden cardiac arrest in people with epilepsy in the community (2015) (41)
The Natural History of Epilepsy in the Era of New Antiepileptic Drugs and Surgical Treatment (2003) (41)
Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability (2007) (41)
Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome (1996) (40)
The impact of levetiracetam on challenging behavior (2006) (40)
Classification of the Epilepsies: Time for a Change? (1999) (39)
Psychiatric Comorbidities in People With Epilepsy. (2020) (39)
Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy (1996) (39)
On the addition of units and nonunits mod m (2009) (39)
Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy. (2008) (38)
Primary care treatment of epilepsy with phenobarbital in rural China: Cost‐outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project (2008) (38)
Primary care treatment of epilepsy with phenobarbital in rural China: Cost‐outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project (2008) (38)
Neuroimaging in epilepsy. (2018) (38)
Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis (2012) (38)
Prevalence and factors associated with convulsive status epilepticus in Africans with epilepsy (2015) (37)
Sudden unexpected deaths in epilepsy—where are we now? (1996) (37)
Epilepsy in China: major progress in the past two decades (2021) (37)
Clinical and neurophysiologic features of active convulsive epilepsy in rural Kenya: A population‐based study (2010) (36)
New antiepileptic drugs in practice – how do they perform in the real world? (2005) (35)
REMISSION IN EPILEPSY - TERMINAL AND CUMULATIVE REMISSION OF NEWLY-DIAGNOSED EPILEPSY IN THE NATIONAL GENERAL-PRACTICE STUDY OF EPILEPSY - A PROSPECTIVE POPULATION-BASED STUDY (1995) (35)
Demonstration Project on Epilepsy in Brazil: situation assessment. (2007) (35)
Neurological disease in a defined population: the results of a pilot study in two general practices. (1996) (35)
A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy (2018) (35)
Ketogenic dietary therapies for adults with epilepsy: Feasibility and classification of response (2014) (35)
Knowledge, attitudes, and stigma towards epilepsy in different walks of life: A study in Georgia (2013) (35)
Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotype (2015) (35)
Lacosamide Serum Concentrations in Adult Patients With Epilepsy: The Influence of Gender, Age, Dose, and Concomitant Antiepileptic Drugs (2014) (34)
Phenobarbital: missing in action. (2012) (34)
Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up (2012) (34)
Sudden unexpected death in epilepsy. Risk factors, possible mechanisms and prevention: a reappraisal. (2006) (33)
Training the trainers and disseminating information: a strategy to educate health professionals on epilepsy. (2007) (33)
No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy (2009) (33)
Demonstration project on epilepsy in Brazil: outcome assessment. (2007) (33)
Epilepsy prevalence and prescribing patterns in England and Wales (2002) (33)
Amygdala sclerosis in sudden and unexpected death in epilepsy (1999) (33)
Epidemiology, pathophysiology and putative genetic basis of carbamazepine‐ and oxcarbazepine‐induced hyponatremia (2016) (32)
Cost Minimization Analysis of Antiepileptic Drugs in Newly Diagnosed Epilepsy in 12 European Countries (2000) (32)
A Pharmacoepidemiologic Study of Factors Influencing the Outcome of Treatment with Lamotrigine in Chronic Epilepsy (2001) (32)
Stigma scale of epilepsy: the perception of epilepsy stigma in different cities in Brazil. (2008) (32)
NHS services for epilepsy from the patient’s perspective: a survey of primary, secondary and tertiary care access throughout the UK (2000) (32)
A comprehensive community epilepsy programme: the Nakuru project (1991) (32)
Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients (2017) (32)
Overall and cause-specific premature mortality in epilepsy: A systematic review (2018) (32)
Acute psychological disorders in patients with epilepsy: a nation-wide study (1996) (31)
Incidence of epilepsy is now higher in elderly people than children (1998) (31)
Identifying and mitigating Sudden Unexpected Death in Epilepsy (SUDEP) risk factors (2018) (31)
The clinical impact of epilepsy genetics (2001) (31)
Partial epilepsy with pericentral spikes: A new familial epilepsy syndrome with evidence for linkage to chromosome 4p15 (2002) (31)
Audit of practice in SUDEP post mortems and neuropathological findings. (2015) (30)
Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent. (1997) (30)
Differences in the use of health services among people with and without epilepsy in the United Kingdom: socio-economic and disease-specific determinants (2002) (30)
Overview of the Demonstration Projects (2002) (30)
Sudden unexpected death: a rare event in a large community based prospective cohort with newly diagnosed epilepsy and high remission rates (1999) (29)
Can we predict a favourable response to Ketogenic Diet Therapies for drug-resistant epilepsy? (2013) (29)
Impaired intracortical inhibition demonstrated in vivo in people with Dravet syndrome (2017) (29)
Peripheral leukocyte profile in people with temporal lobe epilepsy reflects the associated proinflammatory state (2016) (28)
Epilepsy: getting the diagnosis right (1997) (28)
Epilepsy and driving (2005) (28)
Atypical face shape and genomic structural variants in epilepsy (2012) (28)
Cognitive and mood effects of phenobarbital treatment in people with epilepsy in rural China: a prospective study (2012) (27)
Headache and Epilepsy (2013) (27)
Seasonality as a risk factor for sudden unexpected death in epilepsy: A study in a large cohort (2010) (27)
European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice (2010) (27)
Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study (2020) (27)
Multicultural challenges in epilepsy (2011) (27)
Tetramethylenedisulfotetramine intoxication presenting with de novo Status Epilepticus: a case series. (2012) (27)
The comorbid relationship between migraine and epilepsy: a systematic review and meta‐analysis (2015) (27)
Stigma and attitudes on epilepsy a study: with secondary school students. (2007) (27)
Suicide risk in people with epilepsy taking antiepileptic drugs (2013) (26)
Suicidality in Epilepsy and Possible Effects of Antiepileptic Drugs (2010) (26)
Seizures after Ischemic Stroke: A Matched Multicenter Study (2021) (26)
Myoclonic epilepsy of late onset in trisomy 21. (1995) (26)
Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy (2012) (26)
The relation between cortisol and functional connectivity in people with and without stress‐sensitive epilepsy (2018) (25)
Epilepsy perception amongst university students: a survey. (2007) (25)
The impact of age on lamotrigine and oxcarbazepine kinetics: A historical cohort study (2013) (25)
Generic substitution of antiepileptic drugs (2010) (25)
Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: Prevalence and clinical characteristics (2015) (25)
The pharmacological treatment of depression in adults with epilepsy (2008) (25)
Long‐term outcome of phenobarbital treatment for epilepsy in rural China: A prospective cohort study (2013) (25)
Change in Stroke Incidence from a Population-Based Intervention Trial in Three Urban Communities in China (2007) (25)
The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre (2011) (25)
Sulthiame in adults with refractory epilepsy and learning disability: an open trial (2002) (24)
COVID‐19 vaccine take‐up rate and safety in adults with epilepsy: Data from a multicenter study in China (2021) (24)
The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre (2009) (24)
An Economic Appraisal of Carbamazepine, Lamotrigine, Phenytoin and Valproate as Initial Treatment in Adults with Newly Diagnosed Epilepsy (1998) (24)
Ictal ECG changes in temporal lobe epilepsy. (1995) (24)
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis (2017) (24)
Retention of perampanel in adults with pharmacoresistant epilepsy at a single tertiary care center (2017) (24)
Priority concerns for people with intellectual and developmental disabilities during the COVID-19 pandemic (2020) (24)
Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals. (2012) (24)
Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy (2019) (24)
Practical Aspects of the Use of Topiramate in Patients with Epilepsy (1997) (23)
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force (2021) (23)
Levetiracetam and Partial Seizure Subtypes: Pooled Data from Three Randomized, Placebo‐controlled Trials (2003) (23)
Decreasing the risk of sudden unexpected death in epilepsy: structured communication of risk factors for premature mortality in people with epilepsy (2018) (23)
Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy. (2011) (23)
Perampanel in the general population and in people with intellectual disability: Differing responses (2017) (22)
Erythrocyte and plasma fatty acid profiles in patients with epilepsy: Does carbamazepine affect omega-3 fatty acid concentrations? (2008) (22)
Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks (2018) (22)
The prevalence and treatment gap of epilepsy in Tbilisi, Georgia (2012) (22)
Incidence of convulsive epilepsy in a rural area in Kenya (2013) (21)
Levels of stigmatization of patients with previously untreated epilepsy in northern Ecuador. (1995) (21)
Non-Convulsive Status Epilepticus Presenting as a Psychiatric Condition (1996) (21)
Marital adjustment for patients with epilepsy in China (2013) (21)
Electroencephalographic features of convulsive epilepsy in Africa: A multicentre study of prevalence, pattern and associated factors (2016) (20)
Incidence of sudden unexpected death in epilepsy in community-based cohort in China (2017) (20)
A historical perspective on the mortality associated with chronic epilepsy (1997) (20)
Cancer risk in people with epilepsy using valproate‐sodium (2012) (20)
An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy (2017) (20)
Somatic complications of epilepsy surgery over 25 years at a single center (2017) (19)
The neurological founding fathers of the National Society for Epilepsy and of the Chalfont Centre for Epilepsy. (1993) (19)
Q8IYL2 is a candidate gene for the familial epilepsy syndrome of Partial Epilepsy with Pericentral Spikes (PEPS) (2011) (19)
Vigabatrin therapy for refractory complex partial seizures: review of major European trials (2011) (19)
New Drugs for Epilepsy (1985) (18)
Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy (2015) (18)
Under representation of people with epilepsy and intellectual disability in research (2018) (18)
The pharmacological treatment of depression in adults with epilepsy. (2008) (18)
Global Campaign Against Epilepsy. Overview of the demonstration projects. (2002) (18)
Correction: Epilepsy Is a Risk Factor for Sudden Cardiac Arrest in the General Population (2012) (18)
Burden of epilepsy in rural Kenya measured in disability-adjusted life years (2014) (18)
Research in Epilepsy: Development Priorities for Developing Nations (2003) (18)
Training medical students to improve the management of people with epilepsy. (2007) (18)
Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study. (2020) (18)
Can slow breathing exercises improve seizure control in people with refractory epilepsy? A hypothesis (2010) (18)
Suicide and epilepsy: do antiepileptic drugs increase the risk? (2015) (18)
The British Neurological Surveillance Unit: a nation-wide scheme for the ascertainment of rare neurological disorders. (1995) (18)
Mosaicism of a missense SCN1A mutation and Dravet syndrome in a Roma/Gypsy family (2010) (18)
Absence status (1990) (17)
Evolution of visual field loss over ten years in individuals taking vigabatrin (2013) (17)
Prone sleeping and SUDEP risk: The dynamics of body positions in nonfatal convulsive seizures (2016) (17)
What can be done to reduce the risk of SUDEP ? (2010) (17)
Testing association of rare genetic variants with resistance to three common antiseizure medications (2020) (17)
Partial epilepsy syndrome in a Gypsy family linked to 5q31.3‐q32 (2009) (17)
Value of video monitoring for nocturnal seizure detection in a residential setting (2016) (17)
The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: A study on levetiracetam (2006) (17)
Felbamate as add-on therapy. (1996) (17)
Epilepsy-related clinical characteristics and mortality: A systematic review and meta-analysis (2015) (16)
The long-term course of temporal lobe epilepsy: From unilateral to bilateral interictal epileptiform discharges in repeated video-EEG monitorings (2017) (16)
Neurological disorders: a public health approach. Epilepsy (2006) (16)
Antiepileptic drug discontinuation by people with epilepsy in the general population (2017) (16)
Counterfeit antiepileptic drugs threaten community services in Guinea-Bissau and Nigeria (2015) (16)
Towards a coherent public-health analysis for epilepsy (1999) (16)
Magnitude and factors associated with nonadherence to antiepileptic drug treatment in Africa: A cross‐sectional multisite study (2017) (16)
Artificial intelligence extension of the OSCAR‐IB criteria (2021) (15)
Long-interval intracortical inhibition as biomarker for epilepsy: a transcranial magnetic stimulation study (2018) (15)
Effect of oral contraceptives on lamotrigine levels depends on comedication (2014) (15)
External Validation of a Prognostic Model for Seizure Recurrence Following a First Unprovoked Seizure and Implications for Driving (2014) (15)
Neuroepidemiology in the United Kingdom. (1993) (15)
Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events (2018) (15)
Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries (2020) (14)
Importance of competing risks in the analysis of anti-epileptic drug failure (2007) (14)
Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy (2015) (14)
Comorbidity and premature mortality in epilepsy (2013) (14)
The intriguing relationship between epilepsy and type 1 diabetes mellitus (2016) (14)
The treatment gap in epilepsy: A global perspective (2013) (14)
Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center (2018) (14)
Reasons for not having epilepsy surgery (2021) (14)
Interleukin-1β plasma levels are associated with depression in temporal lobe epilepsy (2015) (14)
Seizures as a clinical manifestation in somatic autoimmune disorders (2019) (14)
Long term retention of retigabine in a cohort of people with drug resistant epilepsy (2014) (14)
Cancer mortality amongst people with epilepsy: A study of two cohorts with severe and presumed milder epilepsy (2009) (14)
Management of chronic epilepsy (2012) (14)
Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis (2017) (13)
Models of community-based primary care for epilepsy in low- and middle-income countries (2020) (13)
Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy (2019) (13)
A home‐based, primary‐care model for epilepsy care in India: Basis and design (2019) (13)
Irrationality Criteria for Mahler′s Numbers (1995) (13)
INFECTIOUS AGENTS AND EPILEPSY (2004) (13)
Epilepsy as a systemic condition: Link with somatic comorbidities (2017) (13)
Epilepsy and Recreational Scuba Diving: An Absolute Contraindication or Can There Be Exceptions? A Call for Discussion (2007) (13)
Has the Time Come to Stratify and Score SUDEP Risk to Inform People With Epilepsy of Their Changes in Safety? (2018) (13)
Transcranial magnetic stimulation as a biomarker for epilepsy. (2017) (12)
Levetiracetam: A new antiepileptic drug for the adjunctive therapy of chronic epilepsy. (2001) (12)
Epilepsy surgery in low- and middle-income countries: A scoping review (2019) (12)
LEVETIRACETAM: A NEW THERAPEUTIC OPTION FOR REFRACTORY EPILEPSY (2003) (12)
Effects of AEDs on biomarkers in people with epilepsy: CRP, HbA1c and eGFR (2010) (12)
The association between systemic autoimmune disorders and epilepsy and its clinical implications. (2020) (12)
Help-seeking strategies for epilepsy by previously untreated patients in northern Ecuador (1992) (12)
Carbamazepine in comparative trials (1999) (12)
Sudden death in epilepsy (2011) (12)
Health service provision for people with epilepsy in sub-Saharan Africa: A situational review (2017) (12)
Knowledge and beliefs about epilepsy among people with and without epilepsy in urban Suriname (2013) (12)
Drivers for the comorbidity of type 2 diabetes mellitus and epilepsy: A scoping review (2020) (12)
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy (2020) (11)
[Managing epilepsy in the primary care network in Brazil: are health professionals prepared?]. (2005) (11)
Comorbidity as an epidemiological construct (2016) (11)
National Epilepsy movement in Brazil. (2007) (11)
Antiepileptic drugs and suicide risk: could stopping medications pose a greater hazard? (2010) (11)
Historical introduction. The treatment of epilepsy at the National Hospital, Queen Square, 1857-1939: a mirror of the first phase of the modern history of medical and surgical therapy. (1996) (11)
Pros and Cons for the Development of New Antiepileptic Drugs (2002) (11)
An Audit of the Perceived Efficacy and Tolerability of Gabapentin Therapy in an Out-Patient Cohort with Chronic Epilepsy (1999) (11)
The yield of long‐term electrocardiographic recordings in refractory focal epilepsy (2019) (11)
Allopurinol as an add-on drug in the management of intractable epilepsy (1988) (11)
Sodium valproate for epilepsy in rural China: An efficacy and safety assessment in primary care (2012) (11)
Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor (2015) (11)
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. (2000) (11)
The ILAE classification of seizures and epilepsies: implications for the clinic (2018) (11)
The Use of Caffeine by People with Epilepsy: the Myths and the Evidence (2019) (10)
A descriptive survey of long-term residents with epilepsy and intellectual disability at the Chalfont Centre: is there a relationship between maladaptive behaviour and magnetic resonance imaging findings? (1999) (10)
A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine (2019) (10)
Epilepsy in the community. (1988) (10)
Can natural ways to stimulate the vagus nerve improve seizure control? (2017) (10)
Assessing the role of rare genetic variants in drug‐resistant, non‐lesional focal epilepsy (2021) (10)
Headache in people with epilepsy (2021) (10)
Periodic lateralized epileptiform discharges (PLEDs) as the sole electrographic correlate of a complex partial seizure. (2005) (10)
Male Monozygotic Twins Discordant for Periventricular Nodular Heterotopia and Epilepsy (1999) (10)
A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures (2021) (10)
The socioeconomic, cultural, and emotional implications of starting or withholding treatment in a patient with a first seizure (2008) (10)
Cannabidiol in patients with treatment-resistant epilepsy (2016) (10)
Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective (2014) (10)
SUDEP and seizure safety communication: Assessing if people hear and act (2018) (9)
Web-search trends shed light on the nature of lunacy: Relationship between moon phases and epilepsy information-seeking behavior (2013) (9)
Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program (2021) (9)
Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy (2017) (9)
Antiepileptic drugs and suicidality (2010) (9)
Levetiracetam for prophylactic treatment of pediatric migraine: A randomized double-blind placebo-controlled trial (2019) (9)
Antiepileptic drugs in developing countries (1998) (9)
HHV-7 in adults with drug-resistant epilepsy: a pathological role in hippocampal sclerosis? (2014) (9)
The definition , classification and frequency of NCSE 255 Simon Shorvon Diagnosis of NCSE in children 259 (2005) (9)
Current and emerging drug therapies for the treatment of depression in adults with epilepsy (2018) (9)
A comparison between the 1981 and 2017 International League Against Epilepsy classification of seizure types based on an outpatient setting. (2018) (9)
New drugs for epilepsy. (1998) (9)
Marriage in epilepsy: The impact of the question in knowledge, attitude, and practice surveys (2018) (9)
Cardiac arrhythmias in Dravet syndrome: an observational multicenter study (2020) (9)
Does Early Anti-Epileptic Drug Treatment Alter the Prognosis for Remission of the Epilepsies? (1996) (8)
Suicide risk in epilepsy: where do we stand? (2007) (8)
Sudden Unexpected Death In Patients with Epilepsy (2000) (8)
Learning from the comorbidities of epilepsy (2021) (8)
Genomic and clinical predictors of lacosamide response in refractory epilepsies (2019) (8)
Video games and epilepsy. National survey of photosensitivity and seizures induced by electronic screen games (video games, console games, computer games): Interim findings (1993) (8)
Neurological side effects of COVID‐19 vaccines are rare (2021) (8)
Quantification of respiratory parameters in patients with temporal lobe epilepsy. (2007) (8)
Parasites and epilepsy: Understanding the determinants of epileptogenesis (2019) (8)
Remission of epilepsy. The NGPS. National General Practice Study of Epilepsy. (1995) (8)
Premature mortality in epilepsy: is it preventable? (2011) (8)
Focal epilepsy of probable temporal lobe origin in a Gypsy family showing linkage to a novel locus on 7p21.3 (2011) (8)
Acute and late neurological complications of COVID19: the quest for evidence (2020) (8)
Dysembryoplastic neuroepithelial tumors: A model for examining the effects of pathology versus seizures on cognitive dysfunction in epilepsy (2013) (8)
What the Least Common Multiple Divides, II (1994) (8)
Using Topiramate in Patients with Epilepsy: Practical Aspects (1998) (7)
Neurocysticercosis as a probable risk factor for hippocampal sclerosis. (2018) (7)
Variants in KCNJ11 and BAD do not predict response to ketogenic dietary therapies for epilepsy (2015) (7)
Complex partial status (1996) (7)
Spontaneously Fluctuating Motor Cortex Excitability in Alternating Hemiplegia of Childhood: A Transcranial Magnetic Stimulation Study (2016) (7)
Genetic variants in incident SUDEP cases from a community-based prospective cohort with epilepsy (2019) (7)
Comparing two classification schemes for seizures and epilepsy in rural China (2018) (7)
Efficacy and Tolerability of the New Antiepileptic Drugs: Commentary on the Recently Published Practice Parameters (2004) (7)
Temporal Lobe Epilepsy following Febrile Seizures: Unusually Prolonged Latent Periods (2001) (7)
Idiopathic Generalized Epilepsy Presenting With Hemiconvulsive Seizures (2000) (7)
Patients with epilepsy who die suddenly do not always have cardiac disease. (1999) (7)
Ensuring Appropriate Care in Epilepsy (1998) (7)
APNEA AND BRADYCARDIA DURING EPILEPTIC SEIZURES - RELATION TO SUDDEN DEATHS IN EPILEPSY (1995) (6)
Clinical outcomes of SARS-CoV-2 pandemic in long-term care facilities for people with epilepsy: observational study (2020) (6)
Memory Rehabilitation Strategies in Nonsurgical Temporal Lobe Epilepsy: A Review. (2017) (6)
Sudden Unexpected Death in Epilepsy (2021) (6)
A novel GEFS+ locus on 12p13.33 in a large Roma family (2011) (6)
Prevalence of epilepsy in rural China: a decreasing trend over 12 years (2019) (6)
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications (2021) (6)
The performance of three mortality risk‐adjustment comorbidity indices in a community epilepsy cohort (2015) (6)
Phase clustering in transcranial magnetic stimulation-evoked EEG responses in genetic generalized epilepsy and migraine (2019) (6)
Assessing parents' attitudes towards ketogenic dietary therapies (2014) (6)
Pediatric diagnosis not made until adulthood: a case of Wolf-Hirschhorn syndrome. (2013) (6)
THE PHARMACOKINETICS OF LEVETIRACETAM (UCB LO59) IN PATIENTS WITH INTRACTABLE EPILEPSY (1995) (6)
Understanding of and attitudes towards people with epilepsy among community-based rehabilitation volunteers in Guinea-Bissau (2013) (6)
Traditional practices and perceptions of epilepsy among people in Roma communities in Bulgaria (2020) (6)
Prevalence of MRI abnormalities in people with epilepsy in rural China (2020) (6)
Sudden Unexpected Death in Epilepsy A Personalized Prediction Tool (6)
Genome‐wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug‐resistant epilepsy (2018) (6)
Classifying epilepsy pragmatically: Past, present, and future (2021) (6)
The topographical distribution of epileptic spikes in juvenile myoclonic epilepsy with and without photosensitivity (2017) (6)
Oral health and dental status in people with epilepsy in rural China (2019) (6)
Intellectual deterioration in severe epilepsy. (1987) (6)
Sudden unexpected death in epilepsy: From animals to humans (2012) (5)
Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy. (2013) (5)
Demonstration project on epilepsy in Brazil - WHO/ILAE/IBE global campaign against epilepsy (2007) (5)
Reducing the risk of sudden death during epilepsy monitoring (2013) (5)
Epilepsy as a chronic handicap. (1986) (5)
Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy (2021) (5)
Medication burden in epilepsy: Exploring the impact of non-epilepsy concomitant drugs load (2020) (5)
Stopping drug therapy in epilepsy. (2000) (5)
Infantile spasms and vigabatrin. Visual field defects may be permanent. (1999) (5)
Should single epileptic seizures be treated? (1994) (5)
Automated non-contact detection of central apneas using video (2020) (5)
Impact of the COVID-19 pandemic on people with epilepsy: Findings from the Brazilian arm of the COV-E study (2021) (5)
A Possible Role of the Thalamus in Some Cases of Sudden Unexpected Death in Epilepsy (2007) (5)
Investigative practice into sudden death in epilepsy: A global survey (2019) (5)
The problem of the drug-resistant epilepsies. (2002) (5)
Epilepsy knowledge, attitudes, and practices among primary healthcare providers in an Indian district (2020) (5)
Validity of health insurance data to identify people with epilepsy (2018) (5)
The SeLECT score is useful to predict post-stroke epilepsy (2018) (5)
FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force (2021) (5)
Seizure outcomes in people with drug-resistant focal epilepsy evaluated for surgery but do not proceed (2021) (5)
Deconstructing Dravet syndrome neurocognitive development: A scoping review (2021) (5)
Assessing suicidal risk with antiepileptic drugs (2010) (4)
Epidemiology of Seizures and Epilepsy (2014) (4)
Effects of epilepsy on daily functioning in northern Ecuador: summary of findings of a population-based research project. (1992) (4)
Commentary: Epilepsia's Survey on the Prevalence of Epilepsy (2015) (4)
A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam (2022) (4)
Postictal sleep: Syncope or seizure? (2011) (4)
Anti‐epileptic drug changes and quality of life in the community (2016) (4)
Epilepsy: Trends in new-onset epilepsy — the importance of comorbidities (2016) (4)
Post traumatic epilepsy: there is still much to learn. (2019) (4)
Premature mortality in a Georgian cohort of people with epilepsy (2013) (4)
Remission periods in epilepsy and their relation to long-term prognosis. (1987) (4)
The clinical efficacy of tiagabine (2002) (4)
Association of consciousness impairment and mortality in people with COVID‐19 (2021) (4)
Ring Chromosome 17 Not Involving the Miller-Dieker Region: A Case with Drug-Resistant Epilepsy (2017) (4)
The need for developing comprehensive epilepsy surgery units in India (2012) (4)
Cost–effectiveness of carbamazepine in epilepsy (2006) (4)
Vigabatrin treatment of epilepsy (1991) (4)
Prognosis of adults and children following a first unprovoked seizure. (2021) (4)
Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis (2022) (4)
Declaration of San Antonio, Texas (2007) (3)
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. (2005) (3)
Long-term seizure, psychiatric and socioeconomic outcomes after frontal lobe epilepsy surgery (2022) (3)
Αlpha 5 subunit-containing GABAA receptors in temporal lobe epilepsy with normal MRI (2021) (3)
Editorial: Antiepileptic drugs and suicidality: Much ado about very little? (2010) (3)
Promise and pitfalls of prognostic models for epilepsy surgery (2015) (3)
Smoking prevalence and seizure control in Chinese males with epilepsy (2017) (3)
[Epilepsy and Turner's syndrome: report of a case and review of the literature]. (1990) (3)
Historical perspective: The British contribution to the understanding of neurocysticercosis (2019) (3)
Electro‐clinical criteria and surgical outcome: Is there a difference between mesial and lesional temporal lobe epilepsy? (2017) (3)
Specialist management of routine dental procedures in adults with refractory epilepsy (2014) (3)
The unknown cost of epilepsy misdiagnosis in England and Wales (2007) (3)
Incidence and prevalence of epilepsy and associated factors in a health district in North-West Cameroon: A population survey (2021) (3)
A fitful night's sleep (2010) (3)
Using common genetic variants to find drugs for common epilepsies (2021) (3)
Early treatment does not seem to affect the risk of mortality in epilepsy but the presence of comorbidity may (2011) (3)
Memory Rehabilitation Strategies in Nonsurgical Temporal Lobe Epilepsy: A Review (2017) (3)
Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy. (1999) (3)
Topiramate in newly diagnosed epilepsy: 100 Mg/day as initial target dose (2003) (3)
REMISSION OF INTRACTABLE EPILEPSY IN ELDERLY PATIENTS IN A SELECTED POPULATION IN LONG-TERM RESIDENTIAL CARE (1995) (3)
Exposure to antiepileptic drugs in pregnancy: The need for a family factor framework (2018) (3)
Headache and epilepsy topical collection on secondary headache (2013) (3)
The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workers (2021) (2)
Integer-detecting sequences (1998) (2)
Risk factors for cancer and vascular deaths in patients with epilepsy in a community and a residential population: A case-controlled study (1996) (2)
National demonstration project on epilepsy in Brazil./ Projeto Demonstrativo em Epilepsia no Brasil (2003) (2)
How rational is current anti-epileptic drug treatment? (1997) (2)
POSTICTAL GENERALIZED EEG SUPPRESSION IS NOT A CONSISTENT FINDING IN PEOPLE WITH MULTIPLE CONVULSIVE SEIZURES (2013) (2)
Towards a pragmatic epilepsy classification: Future considerations (2020) (2)
The economic impact of epilepsy (2008) (2)
Prevalence and potential causes of epilepsy in Nigeria (2014) (2)
Response: Comorbidity of Epilepsy (2005) (2)
Reproducibility of Diagnostic Criteria for Ventricular Neurocysticercosis (2017) (2)
Tropical spastic paraparesis (1986) (2)
The burden of epilepsy and unmet need in people with focal seizures (2022) (2)
Translation and validation of an epilepsy-screening questionnaire in three Nigerian languages (2020) (2)
Idiopathic generalised epilepsies: not only for the paediatrician (2003) (2)
Do clinicians use more question marks? (2015) (2)
Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk: A Discrete Event Simulation Model (2016) (2)
Late-life terminal seizure freedom in drug-resistant epilepsy: “Burned-out epilepsy” (2021) (2)
Vector-borne protozoal infections of the CNS: cerebral malaria, sleeping sickness and Chagas disease (2021) (2)
The effect of epilepsy on the brain: Findings of a longitudinal community based quantitative MRI study (2002) (2)
Epilepsy in a health district in North-West Cameroon: Clinical characteristics and treatment gap (2021) (2)
Decreasing the risk of SUDEP: Structured communication of risk factors for premature mortality in people with epilepsy (2018) (2)
Antiepileptic Drugs in Clinical Trials (2008) (2)
Mortality implications and factors associated with nonengagement in a public epilepsy care initiative in a transient population (2020) (2)
Significant hypotension following buccal midazolam administration (2010) (2)
Comorbidity of epilepsy - authors reply. (2005) (2)
Verbal Autopsy Questionnaire (2019) (2)
Genes cut across systems (2016) (2)
Sudden Death and Cardiac Arrythmia With Lamotrigine (2022) (2)
Irrationality and codes (1995) (2)
Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adults (2022) (2)
Nurse Prescribing and the Management of Epilepsy (2006) (1)
Metabolic issues in people with epilepsy (2020) (1)
Competing risks of antiepileptic drug failure: Importance, measurement and analysis (2006) (1)
Transcranial magnetic stimulation as a biomarker of treatment response in children with epilepsy (2020) (1)
[Epilepsy at a psychiatric hospital]. (1990) (1)
[Lennox-Gastaut syndrome of late onset? Report of a case]. (1990) (1)
Temporal trends in the epilepsy treatment gap in low- and low-middle-income countries: A meta-analysis (2022) (1)
In response: Multifactorial basis of epilepsy in patients with neurocysticercosis (2015) (1)
A Population-Based Study on the Long-Term Prognosis of Epilepsy, Prognostic Patterns and Drug Resistance (P1.103) (2016) (1)
Prescribing for epilepsy in adults with Intellectual Disability: A serious conundrum Authors: (2016) (1)
Epilepsy treatment: a paradigm shift is urgently need. (2013) (1)
Somatic symptoms and related disorders in a large cohort of people with epilepsy: A cohort study (2022) (1)
NIFEDIPINE FOR EPILEPSY (1988) (1)
ANTIEPILEPTIC DRUG CHANGE PATTERNS AND QUALITY OF LIFE IN A COMMUNITY-BASED EPILEPSY COHORT (2015) (1)
Seizure‐associated hippocampal volume loss: A longitudinal magnetic resonance study of temporal lobe epilepsy (2002) (1)
Prognostic factors predicting an unprovoked seizure recurrence in children and adults following a first unprovoked seizure (2021) (1)
Current Principles in the Management of Drug-Resistant Epilepsy (2022) (1)
The clinical impact of epilepsy genetics (vol 70, pg 428, 2001) (2001) (1)
Forced normalization with a novel anticonvulsant. (1999) (1)
Sudden unexpected death in epilepsy (SUDEP): A case control study (2000) (1)
A case of mistaken mesial temporal identity (2009) (1)
Cost of pre-surgical evaluation for epilepsy surgery: A single-center experience (2022) (1)
Comment: Improving the care of people with epilepsy and intellectual disabilities (2015) (1)
The certification of deaths due to epilepsy in the UK (2001) (1)
Clinical and neurophysiological features of active convulsive epilepsy in rural Kenya: a population based study (2012) (1)
Concerns about lamotrigine (2021) (1)
Effect of Anti-seizure Medications on Functional Anatomy of Language: A Perspective From Language Functional Magnetic Resonance Imaging (2022) (1)
Clinical characteristics of epilepsy in resource‐limited communities in Punjab, Northwest India (2020) (1)
The Chalfont Centre, Bucks, United Kingdom (2017) (1)
Optimising epilepsy care throughout the Afghan refugee crisis (2021) (1)
Juvenile Myoclonic Epilepsy Refractory to Treatment in a Tertiary Referral Centre (2018) (1)
Comparative mortality in people with epilepsy in a rural Kenyan district (2007) (1)
EPIDEMIOLOGIC SURVEY OF ACUTE PSYCHOLOGICAL DISORDERS IN EPILEPSY (1995) (1)
A cluster‐randomized trial comparing home‐based primary health care and usual clinic care for epilepsy in a resource‐limited country (2022) (1)
Hyperosmolar hyperglycaemic state causing atypical status epilepticus with hippocampal involvement (2021) (1)
Reducing Sudden Unexpected Death in Epilepsy: Considering Risk Factors, Pathophysiology and Strategies (2021) (1)
Valporic acid and prion proteins (2003) (1)
Ketoconazole in the treatment of cryptococcosis of the central nervous system. (1991) (1)
PERAMPANEL USE IN OLDER PEOPLE WITH EPILEPSY: POOLED DATA FROM EUROPEAN OBSERVATIONAL STUDIES (2017) (1)
Preventing neurocysticercosis. (1993) (1)
Vigabatrin and carbamazepine monotherapy for newly diagnosed epilepsy. (1996) (1)
Anticonvulsant Agents: Gabapentin and Pregabalin (2020) (1)
[Analysis of cost minimization of monotherapy antiepileptic treatment in patients with recent diagnosed epilepsy : the situation in Spain]. (2000) (1)
MORTALITY RISK IN PEOPLE WITH CONVULSIVE EPILEPSY: 8 YEARS' FOLLOW-UP OF A COHORT IN RURAL CHINA (2012) (0)
Prematuremortality of epilepsy in low- andmiddle-income countries: A systematic review from theMortality Task Force of the International LeagueAgainst Epilepsy (2016) (0)
Development and validation of a diagnostic aid for convulsive epilepsy in sub-Saharan Africa: a retrospective case-control study. (2023) (0)
Mortality in epilepsy patients in China: Results from the global campaign against epilepsy primary care demonstration project (2006) (0)
WS1-1 Epidemiological study in Asia, a proposed uniform study protocol (2002) (0)
Phase clustering in epilepsy and migraine Phase clustering in transcranial magnetic stimulation-evoked EEG responses in juvenile myoclonic epilepsy and migraine. Running head: Phase clustering in epilepsy and migraine (2019) (0)
Author response: Models of community-based primary care for epilepsy in low- and middle-income countries (2020) (0)
Cancer deaths in people with epilepsy: A study of two different cohorts of people with epilepsy (2005) (0)
Chapter 20 – The Epilepsies (2003) (0)
Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center (2022) (0)
Brief Communication Suicidal ideation in epilepsy and levetiracetam therapy (2007) (0)
KCNH2 variants in a family with epilepsy and Long QT syndrome: a case report and literature review. (2023) (0)
Mortality associated with cysticercosis in a historical cohort from Britain (2021) (0)
Epilepsy in China: major leaps in the last two decades (2021) (0)
Verbal fluency functional magnetic resonance imaging detects anti‐seizure effects and affective side effects of perampanel in people with focal epilepsy (2022) (0)
GENETICS OF EPILEPSY, A DUTCH COHORT STUDY (2012) (0)
IV B12 A demonstration project of Global Campaign Against Epilepsy in people's Republic of China (2002) (0)
Yield and risk associated with prolonged presurgical video-EEG monitoring: a systematic review (2022) (0)
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model. (2023) (0)
Psychiatric comorbidities among people with epilepsy: A population-based assessment in disadvantaged communities (2022) (0)
GEFS plus syndrome in a large Gypsy/Roma family (2011) (0)
Epilepsy Knowledge, Attitudes, and Practices Questionnaire (2020) (0)
Subject Index Vol. 41, 1999 (1999) (0)
018 Optimising selection for epilepsy surgery (2021) (0)
Reader response: Incidence and case fatality rate of COVID-19 in patients with active epilepsy (2020) (0)
Epidemiology of Epilepsy in Nigeria (2021) (0)
The need for a pragmatic seizure classification in clinical trials (2022) (0)
Implementing WHO's Intersectoral Global Action Plan for epilepsy and other neurological disorders in Southeast Asia: a proposal (2023) (0)
The future: moving from phenotypically defined diseases toward pathophysiological systems. (2023) (0)
Idiopathic Generalized Epilepsy Presenting With Hemiconvulsive Seizures (2000) (0)
SUDDEN CARDIAC ARREST IN EPILEPSY: CIRCUMSTANCES AND RISK FACTORS (2013) (0)
Cost‐effectiveness of cenobamate for focal seizures in people with drug‐resistant epilepsy (2023) (0)
ESTIMATION OF THE GLOBAL BURDEN OF ACTIVE EPILEPSY: A META-ANALYTIC APPROACH (2009) (0)
INCREASED PREVALENCE OF ELECTROCARDIOGRAM MARKERS FOR SUDDEN CARDIAC ARREST IN EPILEPSY (2013) (0)
Author response. (2014) (0)
Lamotrigine versus carbamazepine in epilepsy. (1995) (0)
Reply (2016) (0)
Managing epilepsy in primary care (2002) (0)
THE EVOLUTION OF VISUAL FIELD LOSS IN INDIVIDUALS WHO CONTINUE VIGABATRIN THERAPY OVER A 10-YEAR PERIOD (2011) (0)
Serial Quantitative Atlas-based MRI Volumetry to Assess Progressive Neocortical Damage in Epilepsy (2002) (0)
Geodesic Flow of the Modular Surface and Continued Fractions (2019) (0)
Campaña mundial contra la epilepsia: evaluación de un proyecto piloto en la China rural (2008) (0)
Petit mal status. (1990) (0)
Contributors (2019) (0)
CARDIAC ARRHYTHMIAS MAY BE UNDERESTIMATED IN PEOPLE WITH CHRONIC EPILEPSY (2012) (0)
Paroxysmal Kinesigenic Dyskinesia Secondary to Brain Calcification with a Homozygous MYORG Mutation (2021) (0)
SOMATIC CO-MORBIDITIES ARE A MAJOR ISSUE IN PEOPLE WITH EPILEPSY (2012) (0)
MESIAL TEMPORAL LOBE EPILEPSY SYNDROME: CAN AND SHOULD WE DISTINGHUISH IT BECAUSE OF SURGICAL OUTCOME? (2015) (0)
Reply (2017) (0)
Reduction of Retinal Thickness Ipsilateral to Hippocampal Sclerosis in Epilepsy (2021) (0)
THE NATURE OF EPILEPSY (1991) (0)
Age, Comorbidity, Frailty in Observational and Analytic Studies of Neurological Diseases. (2016) (0)
Caffeine and Epilepsy: A systematic review and quantitative analysis (2017) (0)
Seizure: European Journal of Epilepsy Towards a pragmatic epilepsy classification: future considerations (2020) (0)
PERAMPANEL AND CORTICAL EXCITABILITY: A TRANSCRANIAL MAGNETIC STIMULATION STUDY (2014) (0)
Plotse onverwachte dood bij epilepsie, ofwel 'SUDEP' (2013) (0)
Absence status. Reply (1990) (0)
Seizure freedom rates in different epilepsy populations treated with levetiracetam (2006) (0)
Matters arising—Authors response: Is it possible to estimate the SUDEP risk in people with chronic, medically refractory epilepsy? (2010) (0)
Diagnostic criteria for neurocysticercosis (2017) (0)
Increased cancer in epilepsy, or is it fractures? (2018) (0)
BOOK REVIEWS (1994) (0)
CLINICAL FEATURES AND CONSEQUENCES OF ACTIVE CONVULSIVE EPILEPSY IN MULTIPLE SITES IN SUB-SAHARAN AFRICA: A POPULATION-BASED STUDY (2013) (0)
Subjective Handicap of Epilepsy Scale (2014) (0)
Erratum: Factors predicting prognosis of epilepsy after presentation with seizures (Annals of Neurology (2000) 48 (833-840)) (2001) (0)
P6-26 EEG characteristics in people with active epilepsy in urban settings in Georgia (2010) (0)
Epilepsy and Related Disorders (2009) (0)
OPEN TRIAL OF THE OMEGA-3 FATTY ACID, EICOSAPENTAENOIC ACID, IN 10 PATIENTS WITH REFRACTORY EPILEPSY (2010) (0)
DYNAMICS OF CONVULSIVE SEIZURE GENERATION, TERMINATION AND RECOVERY (2015) (0)
ANTIEPILEPTIC DRUG-MONITORING BY INTRAVENOUS MICRODIALYSIS IN PATIENTS WITH EPILEPSY (1995) (0)
Subjective handicap in people with epilepsy in Georgia and Turkey (2013) (0)
Stigma Scale of Epilepsy--Portuguese Version (2013) (0)
Issues affecting women with epilepsy (2016) (0)
Long term efficacy and tolerability of levetiracetam (LEV) in refractory epilepsy (2000) (0)
The increasing challenge of epilepsy in the elderly: shortening hospital admission. (2020) (0)
Mortality in refractory epilepsy: 'Surgically successful' versus the rest (2005) (0)
The comorbidities of epilepsy: A conceptual framework (2019) (0)
Epilepsy Awareness and Stigma Expression Questionnaire (2013) (0)
Cost minimization analysis of monotherapy for antiepileptic treatment in patients with newly diagnosed epilepsy: The position in Spain (2000) (0)
The cost of side-effects to antiepileptic drugs. (1999) (0)
Dynamics of convulsive seizure termination and postictal generalised EEG suppression Running head : Dynamics of seizure termination (2017) (0)
prospective cohort study Long-term risk of developing epilepsy after febrile seizures : A (2012) (0)
Heart Rate Controversies in Epilepsy (2021) (0)
Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective (2014) (0)
Artificial intelligence and MRI: the source of a new epilepsy taxonomy (2022) (0)
A Genetic Basis for Response to the Ketogenic Diet (2014) (0)
RETINAL NERVE FIBER LAYER THICKNESS: A POSSIBLE BIOMARKER OF DRUG RESISTANCE IN EPILEPSY (2014) (0)
Reply (2001) (0)
Vol. 41, 1999 (1999) (0)
Author Correction: Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries (2020) (0)
EEG FINDINGS AND TREATMENT IN JUVENILE MYOCLONIC AND JUVENILE ABSENCE EPILEPSIES (2012) (0)
SOMATIC CO-MORBIDITIES OF EPILEPSY: WHAT ARE THE RISK FACTORS? (2013) (0)
P.5.c.001 Clinical correlates of psychiatric adverse events of anticonvulsant drugs in patients with epilepsy (2007) (0)
The prognosis of epilepsy (2001) (0)
Better meta-analytic methods, but best initial treatment for status epilepticus remains obscure (2015) (0)
Epilepsia em um hospital psiquiátrico./ Epilepsy at a psychiatric hospital. (1990) (0)
NCSE in the benign focal epilepsies of childhood with particular reference to autonomic status epilepticus in Panayiotopoulos syndrome (2005) (0)
PGES IS MORE FREQUENT IN CONVULSIVE SEIZURES ARISING FROM SLEEP (2012) (0)
Epilepsy diagnosis: Pitfalls and treatment consequences (2005) (0)
Secondary Paroxysmal Kinesigenic Dyskinesia with a CASR Mutation (2021) (0)
PAEDIATRIC DIAGNOSIS NOT MADE UNTIL ADILTHOOD: A CASE OF WOLF-HIRSCHHORN SYNDROME (2012) (0)
TMS-evoked EEG potentials demonstrate altered cortical excitability in migraine with aura (2023) (0)
Reducing mortality in epilepsy (2004) (0)
Which drug for partial seizures: Carbamazepine or valproate? (1993) (0)
A population-based longitudinal volumetric MRI study in Epilepsy (2003) (0)
THE EPILEPTIC BRAIN: A STRESSFUL NETWORK (2015) (0)
LATE-LIFE REMISSION IN INTRACTABLE EPILEPSY: "BURNT OUT EPILEPSY'' OR NATURAL HISTORY? (2012) (0)
Epilepsy with centrotemporal spikes: A benign condition with potentially serious consequences (2011) (0)
Talampanel, a New Antiepileptic Drug: Single and Multiple‐dose Pharmacokinetics and Initial One Week Experience in Patients with Chronic Intractable Epilepsy (2003) (0)
A GENETIC BASIS FOR TREATMENT RESPONSE TO THE KETOGENIC DIET (2013) (0)
Familial mesial temporal epilepsy in a Roma population (2010) (0)
Mosaicism for a missense SCN1A mutation and borderline Dravet syndrome in a Roma/Gypsy family (2010) (0)
IHC Electronic Posters – Thursday and Friday Headache Pathophysiology-Imaging and Neurophysiology EP-01-001 Ambient light color variably influences migraine pain intensity and discomfort in the ictal and interictal phase (2017) (0)
The classification of epilepsy and epileptic seizures (2003) (0)
Risk factors for ischemic heart disease and cancer in patients with epilepsy: a population-based control study (1994) (0)
Transcranial magnetic stimulation-evoked electroencephalography responses as biomarkers for epilepsy: A review of study design and outcomes. (2023) (0)
[Sudden unexpected death in epilepsy: SUDEP]. (2013) (0)
Introduction (2016) (0)
Optical Coherence Tomography in Vigabatrin-Exposed Patients: Exploring the Structure-Function Relationship (2010) (0)
Idiopathic first seizure in adult life (1991) (0)
Sudden death in epilepsy - An overview (1998) (0)
Predictors of premature mortality in epilepsy: Author response to Nevalainen et al. (2018) (0)
The pharmacokinetics of levetiracetam and the effect of concomitant medication in patients with intractable epilepsy (2005) (0)
Special Issue on Principles of Autonomous Neurodynamics and Understanding Epilepsy Introduction (2016) (0)
Seizure disorders and pregnancy. (1986) (0)
Rare coding variants in GABAA receptor encoding genes in genetic generalized epilepsies: an exome-based case-control study (2018) (0)
Transcultural perspectives in epilepsy (2003) (0)
Antiepileptic Drugs in Early Clinical Development (2009) (0)
REPLY (2001) (0)
The riveting relationship between epilepsy and type 1 diabetes AUTHORS (2016) (0)
Drug treatment of epilepsy: antiepileptic drugs (2002) (0)
PHENOTYPING DRUG RESPONSE IN EPILEPSY (2012) (0)
A Genome-Wide Association Study Of Sodium Levels And Drug Metabolism In A Carbamazepine And Oxcarbazepine Treated Epilepsy Cohort (2018) (0)
The attitudes and stigma towards people with epilepsy in an urban setting in Georgia (2010) (0)
Assessment of the efficacy of Phenobarbital on a large community-based intervention for epilepsy care in rural China (2005) (0)
MORTALITY IN EPILEPSY - REPLY (1994) (0)
CLINICAL FEATURES OF CONVULSIVE STATUS EPILEPTICUS IN A CHINESE POPULATION (2009) (0)

This paper list is powered by the following services:

Other Resources About Ley Sander

en.wikipedia.org

What Schools Are Affiliated With Ley Sander?

Ley Sander is affiliated with the following schools: